Study reveals bleach ineffective against common superbug in hospitals
HQ Team November 23, 2023: The widely used disinfectant, bleach, commonly employed in hospitals for cleaning medical equipment and surfaces is ineffective against.
Drugs
Health
Medical
Drugs
Health
Medical
Patient perceptions shed light on food allergy development: Study
HQ Team November 23, 2023: A recent survey conducted by Northwestern University reveals diverse perspectives among patients and caregivers regarding the development of.
Drugs
Health
Medical
Hydrogel-based diabetes drug to cut need for insulin shots to thrice a year
HQ Team November 22, 2023: Stanford researchers have developed a promising hydrogel-based delivery system that will potentially transform diabetes treatment. This innovative technology,.
Drugs
Health
Pharma
Vampiric tumour cells can hijack human body’s immune cell energy
HQ Team November 22, 2023: Tumour molecules can rob the human body’s immune cells to deprive them of their energy to fuel the.
Climate
Health
Medical
Uncovering hidden costs of lead exposure: New study
HQ Team November 21, 2023: Lead exposure remains a significant worldwide health risk, and a study has quantified its toll on both health.
Drugs
Health
Pharma
Opinion: Food poisoning, deaths took shawarma out of my food menu
By Dr. K. Leelamoni November 21, 2023: Shawarma was a favourite dish of mine and I first came to know about it when.
Drugs
Health
Medical
New therapy shows promise in restoring smell and taste for long Covid
HQ Team November 20, 2023: A new study suggests that targeting the stellate ganglion, known as a “stellate ganglion block,” could restore smell.
Health
Medical
Pharma
Micron gets $23.6m Gates Foundation grant to make needle-free vaccines
HQ Team November 20, 2023: Micron Biomedical, a US Atlanta-based medical device company, announced a $23.6 million grant from the Bill & Melinda.
Drugs
Health
Pharma
Lilly to build $2.5b plant in Germany to make diabetes, obesity devices
HQ Team November 18, 2023: Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5.
Drugs
Health
Pharma
Astellas’ prostate cancer drug for metastasis-free survival gets nod
HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of.